Lanosterol eye drops for cataract treatment
HPBCD was found to deliver lanosterol (a tetracyclic triterpenoid) active substance into the crystalline lens of the eye. This delivery
Category: Uncategorized
Febreeze with double HPBCD concentration for kitchen smell
Febreze Air Effects Kitchen Odor Eliminator has 2X the odor-fighting ingredients vs. base Febreze. Procter & Gamble, the air expert
Nutritional products from Nutrinovex with CD
Nutrinovex Longovit 360 Energy Gel is a food supplement of gel form based on carbohydrates (fructose, isomaltulose, maltodextrin, cyclodextrin, pregelatinized
Application of cyclodextrin containing sliding-ring polymers in oil-well cement
Saudi Arabian Oil Company (inventors: Hasmukh A. Patel, Peter Boul and Carl Thaemlitz) filed a patent application on cyclodextrin containing
Efficacy and safety of sugammadex for neuromuscular blockade reversal in pediatric patients: an updated meta-analysis of randomized controlled trials with trial sequential analysis
Background: A recent survey revealed that extensive off-label use of sugammadex in pediatric anesthesia deserved particular attention. The present study
Special Issue: Cyclodextrin applications in pharmacy, biology, medicine, and environment
This special Issue on “Cyclodextrin Applications in Pharmacy, Biology, Medicine and Environment” edited by Crini, G. and Aleya, L., consisted
Molecular interactions in remdesivir-cyclodextrin systems
In a recently published study intermolecular interactions of remdesivir and various cyclodextrin derivatives were characterized by extensive NMR spectroscopy. The
Use of cyclodextrins in diseases and disorders involving phospholipid dysregulation
A patent application by Knut M. Wittkowski (ASDERA LLC, US) entitled “Use of cyclodextrins in diseases and disorders involving phospholipid
Native Cyclodextrins and Their Derivatives as Potential Additives for Food Packaging: A Review
CDs and their inclusion complexes have been proposed to be used as potential allies in food packaging, especially in active
METHYL-CYCLODEXTRIN FOR USE IN TREATING ENVELOPED VIRUS INFECTIONS SUCH AS SARS-CoV-2
The patent application (1) with priority date of 09. March 2020 claims that methyl bCD preferably with DS 0.7 (Crysmeb)